PRISMA-combined α-blockers and antimuscarinics for ureteral stent-related symptoms: A meta-analysis

BACKGROUND: As a monotherpay, a-blockers and anti-muscarinics are both efficacy for ureteral stent-related symptoms (SRS). The aim of the study was to systematically evaluate their efficacy of a combination therapy for SRS. METHODS: Relevant studies investigating α-blockers and/or anti-muscarinics f...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Yu-ming, Chu, Pei, Wang, Wen-jin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer Health 2017
Materias:
7300
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5319511/
https://www.ncbi.nlm.nih.gov/pubmed/28207522
http://dx.doi.org/10.1097/MD.0000000000006098

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5319511/
https://www.ncbi.nlm.nih.gov/pubmed/28207522
http://dx.doi.org/10.1097/MD.0000000000006098

Ejemplares similares